logo
Pathophysiology of the storage lesion
Age of blood—impact on patient outcomes
Management of postpartum hemorrhage
Blood management for massive hemorrhage in trauma
Role of cell salvage in massive hemorrhage
Fluid replacement and the endothelial glycocalyx
Fluid therapy in trauma patients
Management of blood loss in Jehovah's Witness patients with specific respect to the refusal of allogeneic blood transfusion
Spanish consensus statement on alternatives to allogeneic blood transfusion-2010 update
CRASH-2 study: tranexamic acid in trauma
FOCUS study: transfusion trigger in patients with cardiovascular disease undergoing hip fracture surgery
Hemostatic strategies for minimizing mortality in surgery with major blood loss
The place of prothrombin complex concentrates in the bleeding patient
Novel intravenous iron therapies
Safety of erythropoiesis-stimulating agents in oncology
Detection, evaluation and management of preoperative anemia in the elective orthopedic surgical patient—NATA guidelines
Neuraxial anesthesia and new anticoagulant/antiplatelet drugs: the new ESA guidelines
Novel anticoagulants: first outcome after one year
Iron status in altruistic and autologous blood donors: implications for an extended blood donation age
Investigation of autologous plasma donation safety in pregnant women
Audit of compliance with hospital policy on positive patient identification
Blood wastage: a ten-year report
The “true” costs of blood: the average unit production cost of an erythrocyte concentrate in Spain from a societal perspective
Informed consent and patient understanding of blood transfusion
Patient's and their parent's representations of blood and blood transfusion in a children's hospital: an anthropological study
Blood management in elective knee and hip arthroplasty in Belgium
Abstract withdrawn.
Danish transfusion practice in hip arthroplasty surgery
Northern Ireland audit of preventable anaemia and avoidable transfusion
Audit of blood component support in haematological malignancy
Implementation of a restrictive red blood cell transfusion policy in a regional hospital's medical departments in Israel led to a dramatic drop in blood utilization
Blood management in the ICU: changing transfusion practice in critically ill patients
Point of care testing (POCT) directed use of blood products improves outcome in patients requiring massive transfusion
Ratio of fresh frozen plasma to red cell transfusion in massive transfusion: Does it matter and do we treat elective patients differently to emergency patients?
Postoperative complications related to allogeneic transfusion in major surgery: the multicenter and propective ARISCAT study
Red blood cell (RBC) transfusion-associated respiratory dysfunction (TARD) in critically ill children: a sub-study of the TRIPICU trial
Intraoperative blood transfusion and colloid administration affect post-operative serious adverse events after major surgery
Duration of red-cell storage is associated with post-operative length of stay and new renal complications following cardiac surgery
Effects of red blood cell transfusion on iron metabolism and oxidative stress in critically ill patients
How many patients really benefit from autologous blood donation in hip and knee elective prosthetic surgery? Mathematical simulation and costs analysis in 452 patients at a single Institution
Improved protocol for autologous predonation programme in major orthopedic surgery
Management of the preoperative blood program in Castellon province (Valencian region, Spain)
Correction of a postoperative anaemia with autologous umbilical cord blood derived red blood cells in newborns with a surgical pathology
Improving blood transfusion in knee replacement: efficacy of intraoperative red blood cell salvage
Intraoperative cell salvage (ICS) is associated with lower mortality than homologous blood transfusion (HBT) in ruptured abdominal aortic aneurysm (RAAA)
Centralisation of urological cancer surgery - is cell salvage still effective?
Assessment of the impact of the OrthoPAT cell saver on the morphology of erythrocytes
Is fetal red cell contamination in obstetric cell salvage an important consideration?
Cell salvage and re-infusion: experiences with a new device
Red cell use in primary hip replacements
Case report of autologous transfusion using self-assembled equipment on a Jehovah's Witness
Report on three years of intraoperative cell salvage data collection in Wales
Is there a role for postoperative cell salvage in patients undergoing surgery for hip fracture repair? An observational cohort study
Evaluation of the competence of nursing professionals in blood extractions in the critical patient
Role of preoperative anemia in morbidity and mortality of non-cardiac major surgery: ANESCARDIOCAT study
Perioperative anemia management in colorectal surgery: single-center retrospective cohort evaluation
Descriptive study of perioperative anaemia in patients undergoing gynaecologic oncology surgery
Evaluating whether a low iron status is a predictor of an increased transfusion requirement and so reduce amount of blood transfused in routine THR/TKR cases
Multicenter study on the efficacy of ferric carboxymaltose for correcting preoperative anemia in patients scheduled for major elective surgery: preliminary results
Does administering erythropoietin and iron before cardiac surgery improve post-operative outcomes?
Efficacy of post-operative intravenous iron in elective major urological surgery
The normobaric oxygen paradox (NOP): a safe alternative to postoperative transfusions after hip surgery?
Integrated protocols for the assessment and treatment of iron deficiency anaemia in pregnancy, childbirth and the puerperium
Higher intravenous iron dose in an outpatient anaemia treatment program
Monofer (iron isomaltoside 1000), a novel intravenous iron for treatment of iron deficiency in chronic kidney disease (CKD) patients
Intravenous iron supplementation with Monofer improves quality of life assessments in patients with chronic heart failure
Preferred plasma volume expander in patients requiring fluid therapy: results from a survey performed at the Free University of Brussels
Tromboelastometry for the assessment of hypercoagulation in critically ill cardiac patients
Thromboelastometry in peri-operative gynaecologic and urologic oncology surgery
Allogeneic blood products transfusion in cardiac surgery: changes in standard laboratory and point-of-care coagulation parameters
Evaluation of clinical and cost effectiveness of thromboelastography (TEG®) in cardiac surgery
Platelet transfusion may not reverse the antiplatelet effect of recent Clopidogrel administration
Recombinant tissue factor ROTEM reagent—evaluation and clinical applications
Modulation of coagulation effect of HES by aprotinin: in vitro study
Abstract withdrawn
Blood-sparing effect and safety of tranexamic acid compared to aprotinin in paediatric cardiac surgery
Safety and efficacy of off-label use of recombinant factor VIIa in the treatment of life-threatening haemorrhage during or after surgery
The prevalence and clinical significance of heparin/platelet factor 4 antibodies after cardiac surgery